Charles Frederick Cross FRS (December 11, 1855 April 15, 1935) was a British chemist. Born in Brentford, Middlesex, his father was a schoolmaster turned ...
James M. Roberts - Seattle WA Motoaki Ohtsubo - Seattle WA Andrew C. Koff - Seattle WA Frederick Cross - New York NY
Assignee:
Fred Hutchinson Cancer Research - Seattle WA
International Classification:
G01N 3353
US Classification:
435 71
Abstract:
Methods are provided for determining in biological material the presence or amount human cyclin E polypeptide and/or cyclin E:cell division kinase complexes.
James M. Roberts - Seattle WA Motoaki Ohtsubo - Seattle WA Andrew C. Koff - Seattle WA Frederick Cross - New York NY
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
International Classification:
C07K 1300 C07H 0000
US Classification:
530350
Abstract:
Nucleic acid molecules capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 1 and 1185 of the human cyclin E cDNA sequence shown in FIG. 2. Polypeptides encoded by such nucleic acid molecules, and immunologic binding partners directed to such polypeptides.
James M. Roberts - Seattle WA Motoaki Ohtsubo - Seattle WA Andrew C. Koff - Seattle WA Frederick Cross - New York NY
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
International Classification:
C12N 1500 C12N 1563 C12N 1585 C12Q 168 C07H 2104
US Classification:
435 691
Abstract:
Nucleic acid molecules capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 1 and 1185 of the human cyclin E cDNA sequence shown in FIG. 2. Polypeptides encoded by such nucleic acid molecules, and immunologic binding partners directed to such polypeptides.
James M. Roberts - Seattle WA Motoaki Ohtsubo - Seattle WA Andrew C. Koff - Seattle WA Frederick Cross - New York NY
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
International Classification:
C07K 500 C07K 1400 C07H 2104
US Classification:
530300
Abstract:
Nucleic acid molecules capable of hybridizing under stringent conditions to the nucleotide sequence residing between positions 1 and 1185 of the human cyclin E cDNA sequence shown in FIG. 2. Polypeptides encoded by such nucleic acid molecules, and immunologic binding partners directed to such polypeptides.
Assays For Compounds That Modulate Or Alter Cyclin E Activity
James M. Roberts - Seattle WA Motoaki Ohtsubo - Seattle WA Andrew C. Koff - Seattle WA Frederick Cross - New York NY
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
International Classification:
C12Q 102 C12Q 148 G01N 3350
US Classification:
435 74
Abstract:
Whole cell or cell-free test systems for screening and identifying compounds that modulate or alter Cyclin E activity. Whole cell assays measure the G1 phase of cells in the presence or absence of the test compound. Additional whole cell or cell-free assays measure binding of cyclin E to a cell division kinase, measure cyclin E activity directly, or measure the cell division kinase activity directly in the presence or absence of the test compound.